Travere Therapeutics

Travere Therapeutics is a biopharmaceutical company focused on identifying, developing, and delivering life-changing therapies for people living with rare diseases, particularly those affecting the kidneys and metabolism. They are driven by a deep commitment to the rare disease community, with many team members being patients, survivors, or caregivers themselves. Their mission is to provide hope and support to families navigating life with rare diseases, creating a better future for those affected.

Travere is dedicated to advancing a pipeline of innovative medicines targeting rare diseases with significant unmet needs. They are currently developing treatments for Classical Homocystinuria (HCU), Cystinuria, Focal Segmental Glomerulosclerosis (FSGS), and IgA Nephropathy (IgAN). They are also actively working to improve access to care, particularly for underserved communities, and supporting initiatives to modernize newborn screening protocols for rare diseases. Travere's commitment to patient advocacy and health equity is evident in their partnerships with various patient advocacy organizations and their work with the Rare Disease Diversity Coalition.

Travere Therapeutics emphasizes a culture of compassion and integrity, which extends to supporting employees' well-being. While specific details about job flexibility aren't mentioned, the company's dedication to its values suggests a supportive environment that may offer flexible work arrangements, particularly for caregivers, as highlighted in their "Caregivers and Care Partners" section.

Travere Therapeutics is a biopharmaceutical company focused on improving the lives of people living with rare kidney and metabolic diseases. They are committed to developing and delivering life-changing therapies that address the urgent need for treatment options in these areas. Driven by their dedication to the rare disease community, they work collaboratively with patients, families, and caregivers to create a better future for those affected by these conditions.

Travere Therapeutics fosters a culture of compassion and integrity, where everyone is driven by a deep commitment to improving the lives of people living with rare diseases. The company encourages an environment of belonging and empowerment, valuing diverse perspectives and embracing teamwork and collaboration. This patient-inspired approach is rooted in courage, perseverance, and ambition to advance research, deliver life-changing therapies, and provide hope for a better future for rare disease patients and their families.

Travere Therapeutics is committed to creating a diverse and inclusive workforce that reflects the communities it serves. They prioritize building a multigenerational, multiracial, and multibackground team, and have implemented initiatives aimed at supporting their DEIB goals across recruitment, retention, development, cultural awareness, employee engagement, business practices, and community outreach. Travere believes that diverse teams lead to better organizational performance, an inclusive culture enables success, and their team should reflect the communities they serve.